Reata Pharma (RETA) reported Q1 EPS of ($1.33), $0.82 better than the analyst estimate of ($2.15). Revenue for the quarter came in at $910 thousand versus the consensus estimate of $1.55 million.
Reata Pharma (RETA) reported Q1 EPS of ($1.33), $0.82 better than the analyst estimate of ($2.15). Revenue for the quarter came in at $910 thousand versus the consensus estimate of $1.55 million.